ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Coronavirus

Fujifilm speeds up development of coronavirus testing reagent

Subsidiary Fujifilm Wako Pure Chemical may have head start in development process

Fujifilm's reagent can be put to use as soon as the development work is complete. (Photo by Tomoki Mera)

TOKYO -- Fujifilm Holdings has started to develop a new testing reagent for the novel coronavirus.

There is a growing risk of a reagent shortage.

Reagents are substances used for analysis and synthesis because of the reactions they cause.

Fujifilm intends to introduce its substance as early as possible.

The subsidiary Fujifilm Wako Pure Chemical is carrying out the development.

The reagent will be used as part of a kit employing the polymerase chain reaction method. This method can take the genes in a saliva or other kind of sample and rapidly replicate them a million- or even billionfold.

This makes it possible to identify whether the virus is present in the sample.

The reagent can be put to use as soon as the development work is complete.

Normally, it takes three or four months to develop a reagent. But since the genome information of the novel coronavirus has already been obtained, there is the possibility that the development work can be expedited.

Fujifilm, however, has not disclosed a timeline for the new reagent.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends April 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media